Results 131 to 140 of about 55,913 (181)

Adoptive cell therapy for cancer: combination strategies and biomarkers. [PDF]

Front Immunol
Liu S, Jiang W, Sheng J, Wang L, Cui M.
europepmc   +1 more source

Tumor-Immune Interactions in Pediatric Oral Rhabdomyosarcoma: A Narrative Review on Immuno-Oncology and Emerging Therapies. [PDF]

Children (Basel)
El Meligy OA, Elemam NM, Hassan WA, Talaat IM.   +3 more
europepmc   +1 more source

Cytokine-Induced Killer Cell Immunotherapy Reduces Recurrence in Patients with Early-Stage Hepatocellular Carcinoma. [PDF]

Cancers (Basel)
Kim DH, Kim EM, Lee JS, Kim MN, Kim BK, Kim SU, Park JY, Choi GH, Ahn SH, Lee HW, Kim DY.   +10 more
europepmc   +1 more source

Preclinical evaluation of DC-CIK cells as potentially effective immunotherapy model for the treatment of glioblastoma. [PDF]

Sci Rep
Lück AS, Pu J, Melhem A, Schneider M, Sharma A, Schmidt-Wolf IGH, Maciaczyk J.   +6 more
europepmc   +1 more source

Potential therapeutic roles of natural killer cells in acute myeloid leukemia: a systematic review study. [PDF]

Clin Exp Med
Khani-Eshratabadi M, Motallebzadeh Khanmiri J, Dashti MR, Esmaeili S, Moradi Sani Z, Daei A, Hedayat Hasanabadi M, Saberi Amarghan S, Younesi Moghaddam N, Baradaran B.   +9 more
europepmc   +1 more source

Engineering back-splicing-like sites for enhanced linear RNA expression. [PDF]

Appl Microbiol Biotechnol
Chen X, Sun S, Li K, Zhao H, Li S, Shen Z, Zhang W, Zhu M, Gong C, Hu X.   +9 more
europepmc   +1 more source

Combined immunotherapy with dendritic cells and cytokine-induced killer cells for solid tumors: a systematic review and meta-analysis of randomized controlled trials. [PDF]

J Transl Med
Jiang W, Wang Z, Luo Q, Dai Z, Zhu J, Tao X, Xie Y, Du Y, Jiang L, Chu X, Fu G, Lei Z.   +11 more
europepmc   +1 more source

Monitoring of (Leukemia-Specific) Immune Cells in Stages, Treatment Groups and in the Course of Disease and Therapy Contributes to Qualify Antileukemic Potential and Survival in Patients with AML. [PDF]

Int J Mol Sci
Stein J, Anand P, Abdulmajid J, Hartz A, Unterfrauner M, Feng X, Schmieder N, Kruk L, Bojko P, Schmohl J, Schmid C, Filippini Velázquez G, Schmetzer HM.   +12 more
europepmc   +1 more source

Immune microenvironment and immunotherapy in hepatocellular carcinoma: mechanisms and advances. [PDF]

Front Immunol
Xie D, Liu Y, Xu F, Dang Z, Li M, Zhang Q, Dang Z.   +6 more
europepmc   +1 more source

Long-term survival after local immunotherapy for malignant gliomas: a retrospective study with 20 years follow-up. [PDF]

BMC Immunol
Duan H, He Z, Chen Z, Chen Y, Hu W, Sai K, Zhang X, Xia J, Li Y, Liu R, Zou C, Chen Z, Mou Y.   +12 more
europepmc   +1 more source